Submit a link
Start a discussion
  • Current Event
    3 days ago
    by jasont
    +8 +1

    Americans pay more for prescription drugs than anyone else. Can Amazon Pharmacy change that?

    An Amazon Prime membership already gets you deals on retail goods, snappy deliveries and access to video-streaming content. Now, the e-commerce behemoth says it will also get you free two-day deliveries at the newly-announced Amazon Pharmacy, as well as savings on generic and brand-name medication.

  • Current Event
    8 days ago
    by sasky
    +19 +1

    Amazon launches Amazon Pharmacy for prescription medicine delivery

    Amazon is making its biggest push into the healthcare industry yet with the launch today of Amazon Pharmacy: a new service offering home delivery for prescription medication.

  • Current Event
    2 months ago
    by Chubros
    +22 +1

    Trump signs executive order to lower drug prices

    United States President Donald Trump announced on Sunday he has signed an executive order to reduce drug prices in the US. "My Most Favored Nation order will ensure that our Country gets the same low price Big Pharma gives to other countries. The days of global freeriding at America’s expense are over and prices are coming down FAST! Also just ended all rebates to middlemen, further reducing prices," the president tweeted.

  • Review
    5 years ago
    by Basaglar
    Review
    -2 +1

    Eli Lilly

    Lilly makes medicines that help people live longer, healthier, more active lives. We were founded by Eli Lilly in 1876, and are now the 10th largest pharmaceutical company in the world. http://www.lilly.com

  • Expression
    4 years ago
    by messi
    +24 +1

    What's in a Name? Ask Isis Pharmaceuticals, Which is Becoming Ionis

    Isis Pharmaceuticals on Friday announced that it will change its name to Ionis Pharmaceuticals. The company's shares, which now trade on the Nasdaq under the ticker "ISIS," will trade under the new ticker symbol "IONS." The new ticker symbol will become effective on Tuesday. Ionis Pharmaceuticals did not mention the so-called Islamic State, the terror group also known as ISIS.

  • Current Event
    4 years ago
    by zyery
    +34 +1

    The solution to doping is to extend the blame beyond athletes

    Doping in sport is widespread and shows little sign of abating. Athletes are dropping out of the Rio Olympics like flies. Maria Sharapova was banned for two years after testing positive for meldonium; a Romanian kayaking team failed their drug test, disqualifying them pending further investigations; and the International Olympic Committee announced that they could ban up to 31 athletes from competing because retests of their samples collected during the 2008 Beijing Olympics indicated the presence of banned substances.

  • Current Event
    4 years ago
    by everlost
    +20 +1

    Coming soon: $100 EpiPen alternative

    Mark Baum believes the relentless EpiPen price hikes are "shameful" and his company is plotting a $100 alternative for the lifesaving allergy treatment. Baum, known for offering a $1 substitute for the $750 AIDS drug Daraprim, told CNNMoney on Tuesday that his company Imprimis Pharmaceuticals (IMMY) has been quietly working on a compounded version of EpiPen for months. The company hopes to have it ready by the end of the year.

  • Current Event
    4 years ago
    by rawlings
    +29 +1

    Sorry, not sorry: Mylan CEO refuses to apologize for EpiPen price hikes

    Does your EpiPen cost a fortune? Blame Mylan for that. Anger and bipartisan disgust toward Mylan, the drugmaker that sells the EpiPen, increased after the company hiked up prices to $608 for a two-pack, up from about $100 in 2009. The company is also under fire for other shady practices involving the CEO’s mother. But Mylan's chief executive says not so fast."I think many people incorrectly assume we make $600 off each EpiPen.

  • Current Event
    4 years ago
    by ilyas
    +17 +1

    Mylan says EpiPen pretax profits 60% higher than it told Congress: Report

    Mylan said on Monday the auto-injector EpiPen pretax profits were higher than it told Congress, according to Dow Jones.

  • Current Event
    3 years ago
    by hxxp
    +22 +1

    Students recreate Daraprim, drug that sells for thousands in US, for $20

    For $US20, a group of high school students has created 3.7 grams of an active ingredient used in the medicine Daraprim, which would sell in the United States for between $US35,000 and $US110,000. Pyrimethamine, the active ingredient in Daraprim, treats a parasitic infection in people with weak immune systems such as pregnant women and HIV patients.

  • Current Event
    3 years ago
    by hiihii
    +7 +1

    Actavis UK raised drug prices 12,000 percent, watchdog finds

    Drug maker Actavis UK broke competition law by raising prices of hydrocortisone tablets by more than 12,000 percent, Britain's competition watchdog said in a provisional ruling on Friday. Higher prices meant the tablets cost Britain's National Health Service (NHS) about 70 million pounds last year, up from about 522,000 pounds previously, the CMA said.

  • Current Event
    3 years ago
    by wetwilly87
    +6 +1

    OxyContin goes global — “We’re only just getting started”

    OxyContin is a dying business in America. This is the third part of a Los Angeles Times investigation exploring the role of OxyContin in the nation’s opioid epidemic. With the nation in the grip of an opioid epidemic that has claimed more than 200,000 lives, the U.S. medical establishment is turning away from painkillers. Top health officials are discouraging primary care doctors from prescribing them for chronic pain, saying there is no proof they work long-term and substantial evidence they put patients at risk.

  • Current Event
    3 years ago
    by zritic
    +20 +1

    Martin Shkreli Says ‘Of Course’ He’d Raise Drug Price Again

    Outspoken former pharmaceutical executive Martin Shkreli said the national outrage over drug pricing was blown out of proportion and heightened by the U.S. presidential election, although he conceded he could have predicted the blowback better. “In terms of regret, maybe not seeing that as acutely would’ve been a minor regret,” Shkreli said during an interview on Bloomberg TV Friday. “But because the price increase has stuck, so to speak, I don’t really, that’s the main mission...

  • Current Event
    3 years ago
    by ckshenn
    +1 +1

    CVS Puts Out Generic Competitor To EpiPen At A 6th Of The Price

    CVS is now selling a rival, generic version of Mylan’s EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to consumers. The drugstore chain says it will charge $109.99 for a two-pack of the authorized generic version of Adrenaclick, a lesser-known treatment compared to EpiPen, which can cost more than $600.

  • Current Event
    3 years ago
    by wetwilly87
    +1 +1

    Kaleo Pharma to launch totally free EpiPen alternative

    A totally free alternative to the expensive epinephrine auto-injector EpiPen will soon be available in the United States, thanks to the return of Kaleo Pharma’s auto-injector Auvi-Q. Auvi-Q is an auto-adrenaline-injection system similar to EpiPen. Manufacturer Kaleo had to recall it last fall, but it has been allowed by authorities to return to the market by 14th of February this year.

  • Current Event
    3 years ago
    by messi
    +39 +1

    This Drug Company Just Got Caught Jacking Up the Price of a Baby Medicine by 85,000%

    This week, drug manufacturer Mallinckrodt Pharmaceuticals settled a lawsuit with the US Federal Trade Commission (FTC) for US$100 million, for engaging in illegal anti-competitive behaviour to ensure its continued monopoly over a life-saving medication for infants with epilepsy. More than a decade ago, Acthar Gel sold for $40 a vial, but since it's been acquired by Mallinckrodt, the price has been raised to more than $34,000 a vial, netting the company more than $1 billion in revenue in 2015.

  • Current Event
    3 years ago
    by wildcard
    +4 +1

    Everett claims OxyContin maker allows drug into black market, plans to sue

    Mayor Ray Stephanson is ready to move forward with a civil lawsuit against Purdue Pharma, a drug manufacturer. Mayor Stephanson says the city has internal emails that show the company knowingly allowed OxyContin into the black market, and he claims the city will have to spend tens of millions of dollars to deal with the drug problem now plaguing Everett. Hil Kaman is the city's Public Health and Safety Director, and he's been investigating the problem.

  • Current Event
    3 years ago
    by TNY
    +25 +1

    Mylan faces federal antitrust investigator in EpiPen business

    Federal antitrust regulators are eyeing big drugmaker Mylan's EpiPen business, the company said this week. Mylan, in a statement, said the Federal Trade Commission asked it "months ago" for information about its anti-allergy EpiPen "as part of a preliminary investigation." The disclosure comes nearly five months after two United States senators asked the FTC to investigate whether Mylan violated antitrust laws to protect the auto-injector EpiPen from competition.

  • Current Event
    3 years ago
    by Apolatia
    +24 +1

    A drug company hiked the price of a lifesaving opioid overdose antidote by 500 percent

    Where’s the outrage?

  • Current Event
    3 years ago
    by mariogi
    +30 +1

    This drug just got the FDA's OK -- and an $89K price tag

    A drug sold for years overseas to treat a rare form of muscular dystrophy was OKed Thursday by the FDA to be sold in the U.S., but it comes at a high price. The Wall Street Journal reports the now-FDA-approved deflazacort will be offered by Marathon Pharmaceuticals for $89,000 or so a year, up to 70 times its cost outside the U.S.; Marathon CFO Babar Ghias tells the Washington Post the net price will be $54,000 after rebates and discounts. Some who rely on it to treat Duchenne muscular dystrophy...